SASebastián Albertí

Sebastián Albertí

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Sebastián Albertí has a total of 30 co-authors. Here are the top co-authors by number of shared publications:

  • Guadalupe Cortés

    Institut Universitari d′Investigacions en Ciències de la Salut (IUNICS), Universitat de les Illes Balears (UIB), Palma de Mallorca,1 Departamento Médico, GlaxoSmithKline, Tres Cantos,2 Servicio de Microbiología, Hospital Lozano Blesa, Zaragoza,3 Servicio de Microbiología, Hospital Ramón y Cajal,4 Servicio de Microbiología, Hospital General Universitario Gregorio Marañón, Madrid,6 Servicio de Microbiología, Hospital Clínico, Salamanca, Spain5

    6 shared publications
  • Beatriz de Astorza

    Unidad de Investigación,1 Servicio de Anatomía Patológica, Hospital Universitario Son Dureta,4 Área de Microbiología, Departamento de Biología, Universidad de las Islas Baleares and IMEDEA (CSIC-UIB),2 Institut Universitari d′Investigació en Ciències de la Salut (IUNICS), Palma de Mallorca,3 Depto. de Inmunología, Centro de Investigaciones Biológicas (CSIC), Madrid, Spain5

    3 shared publications
  • Carles Saus

    Unidad de Investigación,1 Servicio de Anatomía Patológica, Hospital Universitario Son Dureta,4 Área de Microbiología, Departamento de Biología, Universidad de las Islas Baleares and IMEDEA (CSIC-UIB),2 Institut Universitari d′Investigació en Ciències de la Salut (IUNICS), Palma de Mallorca,3 Depto. de Inmunología, Centro de Investigaciones Biológicas (CSIC), Madrid, Spain5

    2 shared publications
  • Cesar García-Rey

    Institut Universitari d′Investigacions en Ciències de la Salut and Departament de Biologia, Universitat de les Illes Balears, Palma de Mallorca,1 Departamento Médico, GlaxoSmithKline, Tres Cantos,2 Servicio de Microbiología, Hospital Clínico Universitario y Facultad de Medicina, Instituto Valenciano de Microbiología, Valencia, Spain3

    2 shared publications
  • Dolores Álvarez

    Unidad de Investigación,1 Servicio Anatomía Patológica, Hospital Universitario Son Dureta,3 Área de Microbiología, Departamento de Biologia, Universidad de las Islas Baleares and IMEDEA (CSIC-UIB), Palma de Mallorca, Spain2

    2 shared publications
  • Lorenzo Aguilar

    Institut Universitari d′Investigacions en Ciències de la Salut (IUNICS), Universitat de les Illes Balears (UIB), Palma de Mallorca,1 Departamento Médico, GlaxoSmithKline, Tres Cantos,2 Servicio de Microbiología, Hospital Lozano Blesa, Zaragoza,3 Servicio de Microbiología, Hospital Ramón y Cajal,4 Servicio de Microbiología, Hospital General Universitario Gregorio Marañón, Madrid,6 Servicio de Microbiología, Hospital Clínico, Salamanca, Spain5

    2 shared publications

Latest Publications

  • Open Access

    Survey of emm -Like Gene Sequences from Pharyngeal Isolates of Group C and Group G Streptococci Collected in Spain

    by Sebastián Albertí, Cesar García-Rey, María Isabel García-Laorden, Rafael Dal-Ré, Juan García-De-Lomas

    We conducted a nationwide surveillance of the variable 5′ emm -like (M-like protein gene) sequences from 214 pharyngeal group C and group G streptococci. Almost 75% of the isolates exhibited emm or emm -like sequences previously described. We identified six new 5′ emm -like regions, and almost 23% of the isolates were nontypeable. Five emm -like sequences accounted for more than 50% of the isolates in group C and group G, suggesting horizontal gene transfer between strains of different species.


  • Open Access

    Streptococcus pyogenes Pharyngeal Isolates with Reduced Susceptibility to Ciprofloxacin in Spain: Mechanisms of Resistance and Clonal Diversity

    by Sebastián Albertí, Guadalupe Cortés, Cesar García-Rey, Carmen Rubio, Fernando Baquero, José Ángel García-Rodríguez, Emilio Bouza, Lorenzo Aguilar

    A survey of emm gene sequences and an analysis of the pulsed-field electrophoretic profiles of 30 Streptococcus pyogenes isolates with reduced susceptibilities to ciprofloxacin detected the prevalence of isolates with emm type 6 and considerable genetic diversity among isolates. The mechanism of ciprofloxacin resistance in these isolates was based on point mutations in topoisomerase IV subunit C encoded by parC , mainly replacement of serine-79 by alanine.


  • Open Access

    Interaction between Complement Regulators and Streptococcus pyogenes: Binding of C4b-Binding Protein and Factor H/Factor H-Like Protein 1 to M18 Strains Involves Two Different Cell Surface Molecules

    by David PérEz-Caballero, Isabel García-Laorden, Guadalupe Cortés, Michael R. Wessels, Santiago RodrígUez de CórDoba, Sebastián Albertí

    Streptococcus pyogenes, or group A Streptococcus, is one of the most frequent causes of pharyngitis and skin infections in humans. Many virulence mechanisms have been suggested to be involved in the infectious process. Among them is the binding to the bacterial cell surface of the complement regulatory proteins factor H, factor H-like protein 1 (FHL-1), and C4b-binding protein. Previous studies indicate that binding of these three regulators to the streptococcal cell involves the M protein encoded by the emm gene. M-type 18 strains are prevalent among clinical isolates and have been shown to interact with all three complement regulators simultaneously. Using isogenic strains lacking expression of the Emm18 or the Enn18 proteins, we demonstrate in this study that, in contradistinction to previously described S. pyogenes strains, M18 strains bind the complement regulators factor H, FHL-1, and C4b-binding protein through two distinct cell surface proteins. Factor H and FHL-1 bind to the Emm18 protein, while C4BP binds to the Enn18 protein. We propose that expression of two distinct surface structures that bind complement regulatory proteins represents a unique adaptation of M18 strains that enhances their resistance to opsonization by human plasma and increases survival of this particular S. pyogenes strain in the human host. These new findings illustrate that S. pyogenes has evolved diverse mechanisms for recruitment of complement regulatory proteins to the bacterial surface to evade immune clearance in the human host.


  • C3 Promotes Clearance ofKlebsiella pneumoniaeby A549 Epithelial Cells

    by Beatriz de Astorza, Guadalupe Cortés, Catalina Crespí, Carles Saus, José María Rojo, Sebastián Albertí

    The airway epithelium represents a primary site for contact between microbes and their hosts. To assess the role of complement in this event, we studied the interaction between the A549 cell line derived from human alveolar epithelial cells and a major nosocomial pathogen,Klebsiella pneumoniae, in the presence of serum. In vitro, we found that C3 opsonization of poorly encapsulatedK. pneumoniaeclinical isolates and an unencapsulated mutant enhanced dramatically bacterial internalization by A549 epithelial cells compared to highly encapsulated clinical isolates. Local complement components (either present in the human bronchoalveolar lavage or produced by A549 epithelial cells) were sufficient to opsonizeK. pneumoniae. CD46 could competitively inhibit the internalization ofK. pneumoniaeby the epithelial cells, suggesting that CD46 is a receptor for the binding of complement-opsonizedK. pneumoniaeto these cells. We observed that poorly encapsulated strains appeared into the alveolar epithelial cells in vivo but that (by contrast) they were completely avirulent in a mouse model of pneumonia compared to the highly encapsulated strains. Our results show that bacterial opsonization by complement enhances the internalization of the avirulent microorganisms by nonphagocytic cells such as A549 epithelial cells and allows an efficient innate defense.


  • Survey of emm Gene Sequences from Pharyngeal Streptococcus pyogenes Isolates Collected in Spain and Their Relationship with Erythromycin Susceptibility

    by Sebastián Albertí, CésAr García-Rey, María A. DomínGuez, Lorenzo Aguilar, Emilia Cercenado, Miguel Gobernado, Adela García-Perea

    We conducted a nationwide survey of the variable 5′ emm (M protein gene) sequences from 614 pharyngeal Streptococcus pyogenes isolates susceptible (299 isolates) and resistant (315 isolates) to erythromycin that were isolated in Spain from 1996 to 1999. Almost 98% of these isolates had emm sequences in agreement with previously recorded M antigen association. We only identified a new 5′ emm sequence in 17 isolates. Nine different emm types accounted for 85% of the S. pyogenes isolates susceptible to erythromycin. By contrast, only 3 emm types accounted for 70% of the erythromycin-resistant isolates. Further characterization of these isolates by ribotyping and pulsed-field gel electrophoresis indicated that high frequency of erythromycin resistance in Spain is due to few clones.


  • Role of the htrA Gene in Klebsiella pneumoniae Virulence

    by Guadalupe Cortés, Beatriz de Astorza, Vicente J. Benedí, Sebastián Albertí

    We recently described the use of mini-Tn 5 to generate complement-sensitive mutants derived from a complement-resistant Klebsiella pneumoniae clinical isolate deficient in the lipopolysaccharide O side chain. One mutant with a reduced capacity to survive in nonimmune human sera carried the transposon inserted in the htrA gene. We cloned and sequenced the gene and predicted from the deduced amino acid sequence that the putative HtrA homolog contains structural features similar to those of previously described HtrA proteins. To investigate the biological functions and the role of the htrA gene in the virulence of K. pneumoniae , we constructed an isogenic mutant by insertion-duplication mutagenesis. Characterization of the mutant showed that it had greater sensitivity to temperature (50°C) and oxidative stress (H 2 O 2 ) than the parent strain. Furthermore, the htrA mutant produced less capsule, bound more molecules of complement component C3, and was more sensitive to complement and whole-blood killing than was the parent strain. Finally, disruption of the htrA gene in a virulent K. pneumoniae strain caused a reduction of its virulence in a mice model. Our results indicate that the htrA gene plays an important role in the virulence of K. pneumoniae .


  • Top Cited Papers

    Molecular Analysis of the Contribution of the Capsular Polysaccharide and the Lipopolysaccharide O Side Chain to the Virulence of Klebsiella pneumoniae in a Murine Model of Pneumonia

    by Guadalupe Cortés, Nuria Borrell, Beatriz de Astorza, Cristina Gómez, Jaume Sauleda, Sebastián Albertí

    Klebsiella pneumoniae is a common cause of gram-negative bacterial nosocomial pneumonia. Two surface polysaccharides, lipopolysaccharide (LPS) O side chain and capsular polysaccharide (CPS), are critical for the microorganism in causing sepsis, but little is known about their role in pneumonia. To investigate their contribution in the pathogenesis of K. pneumoniae pneumonia, we characterized the host response to bacterial challenge with a highly virulent clinical isolate or with isogenic insertion-duplication mutants deficient in CPS or LPS O side chain in a murine model of pneumonia. Animals challenged intratracheally with the wild-type or LPS O side chain-deficient strain developed pneumonia and became bacteremic before death. Extensive lung lesions as well as pleuritis, vasculitis, and edema were observed by histopathological examination, and polymorphonuclear infiltration was also demonstrated. In contrast, none of the animals challenged with the unencapsulated strain developed pneumonia or bacteremia. Examination of tissue from this group did not identify lung lesions, and none of the infected animals died. Analysis of the early host defense mechanisms that contributed to the clearance of the unencapsulated mutant showed that the levels of C3 deposited on the unencapsulated mutant surface were threefold higher than those for the wild-type and LPS O side chain-deficient strains. Furthermore, phagocytosis of the unencapsulated mutant by human alveolar macrophages (AM) was more efficient than that of the wild-type and LPS O side chain-deficient strains. We conclude that CPS, but not LPS O side chain, is essential for Klebsiella pneumonia because it modulates the deposition of C3 and protects the microorganisms against human AM phagocytosis.


  • Open Access

    Role of Lung Epithelial Cells in Defense against Klebsiella pneumoniae Pneumonia

    by Guadalupe Cortés, Dolores Álvarez, Carles Saus, Sebastián Albertí

    The airway epithelium represents a primary site for the entry of pathogenic bacteria into the lungs. It has been suggested for many respiratory pathogens, including Klebsiella pneumoniae , that adhesion and invasion of the lung epithelial cells is an early stage of the pneumonia process. We observed that poorly encapsulated K. pneumoniae clinical isolates and an isogenic unencapsulated mutant invaded lung epithelial cells more efficiently than highly encapsulated strains independent of the K type. By contrast, the unencapsulated mutant was completely avirulent in a mouse model of pneumonia, unlike the wild-type strain, which produced pneumonia and systemic infection. Furthermore, the unencapsulated mutant bound more epithelially produced complement component C3 than the wild-type strain. Our results show that lung epithelial cells play a key role as a host defense mechanism against K. pneumoniae pneumonia, using two different strategies: (i) ingestion and control of the microorganisms and (ii) opsonization of the microorganisms. Capsular polysaccharide avoids both mechanisms and enhances the virulence of K. pneumoniae .


  • Capsular Polysaccharide Is a Major Complement Resistance Factor in Lipopolysaccharide O Side Chain-Deficient Klebsiella pneumoniae Clinical Isolates

    by Dolores Álvarez, Susana Merino, Juan M. Tomás, Vicente J. Benedí, Sebastián Albertí

    We have previously demonstrated the existence of Klebsiella pneumoniae clinical isolates deficient in the lipopolysaccharide O side chain, the major factor for resistance to complement-mediated killing in this bacterial species. These isolates are complement resistant, and their mechanisms to resist complement were investigated by selecting transposon-generated complement-sensitive mutants. One mutant with a drastically reduced capacity to grow in nonimmune human serum carried the transposon inserted in an open reading frame of a gene cluster involved in capsule synthesis. This mutant produced less capsule, bound more molecules of the complement component C3, and was more sensitive to complement-mediated and opsonophagocytic killings than was the parent strain. Four additional clinical isolates representing four different K serotypes were studied, and results showed that capsular polysaccharide is a major complement resistance factor in these O side chain-deficient isolates.